Keywords: مونو بلوک پر کردن; ACSD; Adult Cardiac Surgery Database; BITA; bilateral internal thoracic arteries; CABG; coronary artery bypass graft surgery; CI; confidence interval; HR; hazard ratio; MABG; multiarterial bypass graft; MVRR; mitral valve repair/replacement; O/E; observed
مقالات ISI مونو بلوک پر کردن (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مونو بلوک پر کردن; SHR; spontaneously hypertensive rats; DCE; dried chokeberry fruit extract; ROS; reactive oxygen species; SAP; systolic arterial pressure; DAP; diastolic arterial pressure; MAP; mean arterial pressure; PP; pulse pressure; CI; cardiac index; HR; heart rate;
Keywords: مونو بلوک پر کردن; PM2.5; particulate matter of aerodynamic diameter â¤Â 2.5 μm; CO; carbon monoxide; CO2; carbon dioxide; RH; relative humidity; ANOVA; analysis of variance; BCM; Bhadrachalam; KTDM; Kothagudem; TVR; Tiruvur; IBP; Ibrahimpatnam; VJA; Vijayawada; Car (ac
Keywords: مونو بلوک پر کردن; drug-eluting stent; left main coronary artery; percutaneous coronary intervention; BP-BES; biodegradable polymer-biolimus eluting stent; CABG; coronary artery bypass grafting; CoCr-EES; cobalt-chromium everolimus-eluting stent; DES; drug-eluting stent; LM
Keywords: مونو بلوک پر کردن; ACS; acute coronary syndrome; CABG; coronary artery bypass grafting; CAD; coronary artery disease; IABP; intra-aortic balloon pump; LM; left main; MACE; major adverse cardiac event; MI; myocardial infarction; NSTEMI; non-ST-elevation myocardial infarction
Keywords: مونو بلوک پر کردن; CAD; coronary artery disease; DAPT; dual anti-platelet therapy; DES; drug eluting stent; DM; diabetes mellitus; L-DAPT; long dual anti-platelet therapy; MI; myocardial infarction; NACE; net adverse cardiovascular event; PCI; percutaneous coronary interven
Keywords: مونو بلوک پر کردن; EOPE; Early Onset Pre-Eclampsia; LOPE; Late Onset Pre-Eclampsia; LV; Left Ventricle; TVR; Total Vascular Resistance; Cardiovascular dysfunction; Echocardiography; Early onset preeclampsia; Late onset preeclampsia; Diastolic dysfunction;
Keywords: مونو بلوک پر کردن; BRS; bioresorbable scaffold; DAPT; dual antiplatelet therapy; MACE; major adverse cardiac event; ST; stent or scaffold thrombosis; TAT; triple antithrombotic therapy; TLF; target lesion failure; TLR; target lesion revascularization; TVF; target vessel fai
Keywords: مونو بلوک پر کردن; ASAN MAIN; ASAN Medical Center-Left MAIN Revascularization; BMS; bare-metal stents; CABG; coronary artery bypass grafting; CI; confidence interval; DES; drug-eluting stent; EES; everolimus-eluting stents; LE MANS; Left Main Coronary Artery Stenting; MACCE
Keywords: مونو بلوک پر کردن; drug-coated balloon; femoropopliteal artery; in-stent restenosis; paclitaxel; peripheral artery disease; ABI; ankle-brachial index; CD; clinically driven; DCB; drug-coated balloon; DES; drug-eluting stent(s); DUS; duplex ultrasonography; ISR; in-stent res
Keywords: مونو بلوک پر کردن; biodegradable polymer; drug-eluting stent(s); durable polymer; meta-analysis; BMS; bare-metal stent(s); BP-DES; biodegradable polymer drug-eluting stent(s); CI; confidence interval; DAPT; dual-antiplatelet therapy; DES; drug-eluting stent(s); DP-DES; dura
Keywords: مونو بلوک پر کردن; Drug-coated balloon; Drug-eluting balloon; In-stent restenosis; Percutaneous coronary intervention; Paclitaxel; Ballon médicamenté; Athérosclérose; Resténose intra-stent; Angioplastie percutanée; Paclitaxel; AMI; acute myocardial infarction; BMS; ba
Keywords: مونو بلوک پر کردن; Echocardiography; Fetal growth restriction; Hemodynamics; Pregnancy; Blood pressure; Cardiac function; A; peak velocity of the A wave; ABPM; ambulatory blood pressure monitoring; BMI; body mass index; BP; blood pressure; DBP; diastolic blood pressure; DTE
Keywords: مونو بلوک پر کردن; Hand-arm; Resonance; TVR; Proprioceptors; Vibration
Keywords: مونو بلوک پر کردن; INTERMACS; Interagency Registry for Mechanically Assisted Circulatory Support; LVAD; left ventricular assist device; TR; tricuspid regurgitation; TVR; tricuspid valve repair;
Keywords: مونو بلوک پر کردن; clinical outcome; fractional flow reserve; stable angina; vessel related; CI; confidence interval; CV; cardiovascular; FFR; fractional flow reserve; HR; hazard ratio; MACE; major adverse cardiovascular event; MI; myocardial infarction; MT; medical therapy
Keywords: مونو بلوک پر کردن; Alcohol-free red wine; Anthocyanins; Malvidin-3-O-glucoside; Blood pressure; Oxidative stress; Magnesium; RW; red wine; AFRW; alcohol-free red wine; ROS; reactive oxygen species; SHR; spontaneously hypertensive rats; eNOS; endothelial nitric oxide synthas
Keywords: مونو بلوک پر کردن; mitral valve replacement; Society of Thoracic Surgeons Database; warfarin use; ACC; American College of Cardiology; ADP; adenosine diphosphate; ASD; atrial septal defect; AVR; aortic valve replacement; BMVR; bioprosthetic mitral valve replacement; CHF; co
Keywords: مونو بلوک پر کردن; CABG; coronary artery bypass graft; DES; drug-eluting stents; LMCA; left main coronary artery; MI; myocardial infarction; PCI; percutaneous coronary intervention; PS; propensity score; TVR; target vessel revascularization; 23;
Keywords: مونو بلوک پر کردن; infective endocarditis; transcatheter aortic valve implantation; transcatheter pulmonary valve implantation; AR; aortic regurgitation; IE; infective endocarditis; PVE; prosthetic valve endocarditis; TAVR; transcatheter aortic valve replacement; TVR; trans
Keywords: مونو بلوک پر کردن; BMS; bare metal stent; CI; confidence interval; DES; drug-eluting stent; LAD; left anterior descending artery; LITA; left internal thoracic artery; MIDCABG; minimally invasive direct coronary artery bypass graft surgery; p-LAD; proximal left anterior desc
Anti-E1E2 antibodies status prior therapy favors direct-acting antiviral treatment efficacy
Keywords: مونو بلوک پر کردن; Hepatitis C; Relapse; Direct-acting antivirals; Neutralizing antibodies; Sustained virological response; E1E2 envelope; HCV; hepatitis C virus; DAA; direct-acting antiviral; SVR; sustained virological response; RBV; ribavirin; PEG-IFN; pegylated-interfero
Predictors of bioresorbable scaffold failure in STEMI patients at 3â¯years follow-up
Keywords: مونو بلوک پر کردن; BRS; bioresorbable scaffolds; DES; drug-eluting stents; DoCE; device-oriented composite endpoint; TLR; target-lesion revascularization; TVR; target-vessel revascularization; ScT; scaffold thrombosis; ScR; scaffold restenosis; ARC; academic research consor
Abciximab/Heparin Therapy for Left Ventricular Assist Device Implantation in Patients With Heparin-Induced Thrombocytopenia
Keywords: مونو بلوک پر کردن; 4T; Thrombocytopenia, Timing of platelet count fall, Thrombosis or other sequelae, other causes of Thrombocytopenia; Ab; antibody; ACT; activated clotting time; aPTT; activated partial thromboplastin time; AVR; aortic valve repair; CABG; coronary artery b
Associations Between Surgical Ablation and Operative Mortality After Mitral Valve Procedures
Keywords: مونو بلوک پر کردن; AF; atrial fibrillation; BA; biatrial; C&S; cut-and-sew; CABG; coronary artery bypass grafting; Cryo; cryoablation; LA; left atrial; MV; mitral valve; MVRR; mitral valve repair or replacement; OR; odds ratio; RF; radiofrequency; SA; surgical ablation; STS
Outcomes After Left Main Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting According to Lesion Site
Keywords: مونو بلوک پر کردن; EXCEL; left main stem; lesion site; substudy; CABG; coronary artery bypass grafting; CI; confidence interval; CoCr-EES; cobalt chromium everolimus-eluting stent(s); LM; left main coronary artery; LMCAD; left main coronary artery disease; MI; myocardial in
Long-term follow-up of BVS from a prospective multicenter registry: Impact of a dedicated implantation technique on clinical outcomes
Keywords: مونو بلوک پر کردن; BVS; bioresorbable vascular scaffolds; DAPT; double antiplatelet therapy; DES; drug-eluting stent; IVUS; intravascular ultrasound; MDCT; multiple detector computed tomography; LAD; left anterior descending artery; MI; myocardial infarction; OCT; optical c
The Timing of P2Y12 Inhibitor Initiation in the Treatment of ACS? Does the Evidence Exist in This Era?
Keywords: مونو بلوک پر کردن; ACS; Acute coronary syndrome; PCI; Percutaneous coronary intervention; CABG; Coronary artery bypass grafting; STEMI; ST-segment elevation myocardial infarction; NSTEMI; Non-ST-segment elevation myocardial infarction; MI; Myocardial infarction; CV; Cardiov
Association between P2RY12 gene polymorphisms and adverse clinical events in coronary artery disease patients treated with clopidogrel: A systematic review and meta-analysis
Keywords: مونو بلوک پر کردن; P2RY12; P2Y12 Purinoceptor; CAD; coronary artery disease; RR; risk ratio; ADP; adenosine diphosphate; MI; non-fatal myocardial infarction; ST; stent thrombosis; UA; unstable angina; TVR; target vessel revascularization; NOS; Newcastle-Ottawa scale; CI; co
The Promus Premier everolimus-eluting platinum chromium stent with durable polymer evaluated in a real world all-comer population in Rotterdam cardiology hospital (the P-SEARCH registry)
Keywords: مونو بلوک پر کردن; ACC; American College of Cardiology; ACS; Acute coronary syndrome; AHA; American Heart Association; CABG; Coronary artery bypass graft; CK-MB; Creatine kinase-MB fraction; CTO; Chronic total occlusion; DES; Drug-eluting stent; DM; Diabetes mellitus; EeCCS
Clinical Outcomes of patients with coronary artery disease who underwent FFR evaluation of intermediate coronary lesionS- COFFRS study
Keywords: مونو بلوک پر کردن; ACS; Acute Coronary Syndrome; CABG; Coronary Artery Bypass Graft; CAD; Coronary Artery Disease; COURAGE Trial; Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial; DEFER Trial; measurement of fractional flow reserv
Biodegradable Polymer Biolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With Coronary Artery Disease
Keywords: مونو بلوک پر کردن; biodegradable polymer-coated stent(s); biolimus-eluting stent(s); everolimus-eluting stent(s); Nobori; Promus; Xience; BES; biolimus-eluting stent(s); BP-BES; biodegradable polymer biolimus-eluting stent(s); DES; drug-eluting stent(s); DP-EES; durable pol
9-Month Clinical and Angiographic Outcomes of the COBRA Polyzene-F NanoCoated Coronary Stent System
Keywords: مونو بلوک پر کردن; restenosis; stent(s); thrombosis; BMS; bare-metal stent(s); CI; confidence interval; CKMB; creatine kinase-MB; DAPT; dual antiplatelet therapy; DES; drug-eluting stent(s); LL; lumen loss; MI; myocardial infarction; PzF; Polyzene-F; QCA; quantitative cor
Long-Term Safety and Efficacy of Platinum Chromium Everolimus-Eluting Stents in Coronary Artery Disease
Keywords: مونو بلوک پر کردن; coronary artery disease; drug-eluting stent(s); percutaneous coronary intervention; stent design; CABG; coronary artery bypass grafting; CI; confidence interval; CoCr-EES; cobalt chromium everolimus-eluting stent(s); HR; hazard ratio; LL; long lesions; MI
Comparison of Durable-Polymer Zotarolimus-Eluting and Biodegradable-Polymer Biolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease
Keywords: مونو بلوک پر کردن; biolimus; drug-eluting; polymer; randomized clinical trial; stent; zotarolimus; DES; drug-eluting stent(s); MACE; major adverse cardiac event(s); MI; myocardial infarction; PCI; percutaneous coronary intervention; ST; stent thrombosis; TLR; target lesion
The DELTA 2 Registry
Keywords: مونو بلوک پر کردن; drug-eluting stents; left main coronary artery; CABG; coronary artery bypass grafting; CI; confidence interval; CVA; cerebrovascular accident; DES; drug-eluting stent(s); HR; hazard ratio; MACCE; major adverse cardiac and cerebrovascular events(s); MI; my
Should We Still Have Bare-Metal Stents Available in Our Catheterization Laboratory?
Keywords: مونو بلوک پر کردن; drug-eluting stent; dual antiplatelet therapy; high bleeding risk patients; in-stent restenosis; stent thrombogenicity; stent thrombosis; BA9; biolimus A9; BMS; bare-metal stent(s); DAPT; dual antiplatelet therapy; DES; drug-eluting stent(s); EES; everoli
Asymptomatic Carotid Artery Stenosis: Revascularization
Keywords: مونو بلوک پر کردن; CAS; carotid artery stenting; CEA; carotid endarterectomy; CMS; Centers of Medicare and Medicaid; EPD; embolic protection device; FDA; United States Food and Drug Administration; MACCE; major adverse cardiovascular or cerebral event; MI; myocardial infarc
What is the optimal approach to a non- culprit stenosis after ST-elevation myocardial infarction - Conservative therapy or upfront revascularization? An updated meta-analysis of randomized trials
Keywords: مونو بلوک پر کردن; CR; complete revascularization; MACE; major adverse cardiovascular events; PCI; percutaneous coronary intervention; STEMI; ST-segment elevation myocardial infarction; TVR; target vessel revascularization; Multi-vessel coronary artery disease; ST-elevation
Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization
Keywords: مونو بلوک پر کردن; Andersen-Gill; competing risk; left main; weighted composite event(s); win ratio; CABG; coronary artery bypass grafting; CI; confidence interval; CVA; cerebrovascular accident; HR; hazard ratio; MACCE; major adverse cardiac or cerebrovascular event(s); MI
Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients With and Without Acute Coronary Syndrome
Keywords: مونو بلوک پر کردن; ACC; American College of Cardiology; ACS; acute coronary syndrome; AHA; American Heart Association; BMS; bare metal stent; CI; contraindication; CKD; chronic kidney disease; CTO; chronic total occlusion; DAPT; dual antiplatelet therapy; DES; drug-eluting
Impact of the learning curve on procedural results and acute outcome after percutaneous coronary interventions with everolimus-eluting bioresorbable scaffolds in an all-comers population
Keywords: مونو بلوک پر کردن; BVS; bioresorbable vascular scaffold; DES; drug-eluting stent; IVUS; intravascular ultrasound; MACE; major adverse cardiac event; OCT; optical coherence tomography; PLLA; poly-L-lactic acid; SD; standard deviation; TLR; target lesion revascularization; TV
Safety and efficacy of everolimus-eluting stent versus zotarolimus-eluting stent: A meta-analysis of randomized controlled clinical trials and observational studies
Keywords: مونو بلوک پر کردن; EES; everolimus-eluting stent; ZES; zotarolimus-eluting stent; RCTs; randomized controlled clinical trials; MACE; major adverse cardiac events; MI; myocardial infarction; ST; stent thrombosis; TVR; target vessel revascularization; TLR; target lesion revas
Summary of the ESC/EACTS 2014 Guidelines on myocardial revascularization. Prepared by the Czech Society of Cardiology
Keywords: مونو بلوک پر کردن; ACCF/AHA; American College of Cardiology Foundation/American Heart Association; ACS; acute coronary syndromes; AF; atrial fibrillation; ASA; acetylsalicylic acid; BMS; bare-metal stent; CABG; coronary artery bypass grafting; CAD; coronary artery disease;
Impact of previous coronary artery bypass surgery on clinical outcome after percutaneous interventions with second generation drug-eluting stents in TWENTE trial and Non-Enrolled TWENTE registry
Keywords: مونو بلوک پر کردن; DES; drug-eluting stent; PCI; percutaneous coronary intervention; STEMI; ST-elevation myocardial infarction; TVR; target vessel revascularization; Non-ST-ACS; non-ST-elevation acute coronary syndromes; CABG; coronary artery bypass grafting; Drug-eluting s
Anti-interferon-α neutralizing antibody induced telaprevir resistance under the interferon-α plus telaprevir treatment in vitro
Keywords: مونو بلوک پر کردن; HCV; hepatitis C virus; PI; protease inhibitor; TVR; telaprevir; Peg-IFN-α; pegylated interferon-α; RBV; ribavirin; NR; non-response; SVR; sustained virological response; NAb; neutralizing antibody; rIFN; recombinant IFN; Anti-interferon-α neutralizing
Research ArticleShould we await IFN-free regimens to treat HCV genotype 1 treatment-naive patients? A cost-effectiveness analysis (ANRS 95141)
Keywords: مونو بلوک پر کردن; Boceprevir; Chronic hepatitis C; Cost-effectiveness analysis; Direct-acting antivirals; Genotype 1; Interferon-free regimens; Model-based analysis; Telaprevir; Treatment initiation; G1; genotype 1; HCV; hepatitis C virus; TVR; telaprevir; BOC; boceprevir;
Hybrid Coronary Revascularization in 100 Patients With Multivessel Coronary Disease
Keywords: مونو بلوک پر کردن; CABG; coronary artery bypass graft surgery; DES; drug-eluting stent; HCR; hybrid coronary revascularization; LAD; left anterior descending artery; LIMA; left internal mammary artery; MACCE; major adverse cardiac and cerebrovascular events; MI; myocardial
Dedicated Tryton Side Branch Stents used in the treatment of coronary bifurcation lesions
Keywords: مونو بلوک پر کردن; MS-CT; multi-slice CT coronarography; MIP; maximum intensity projection; PCI; percutaneous coronary intervention; MACE; major adverse cardiovascular events; ISR; in-stent restenosis; TVR; target vessel revascularization; LM; left main stem; LAD; left ante
EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
Keywords: مونو بلوک پر کردن; AE; adverse event; ALT; alanine aminotransferase; BMI; body mass index; BOC; boceprevir; BT; viral breakthrough; CPGs; Clinical Practice Guidelines; CYP3A4; cytochrome p450 3A4; DAA; direct-acting antiviral; DVR; delayed virological response; EIA; enzyme